Goldberg M A, Mayo-Smith W W, Papanicolaou N, Fischman A J, Lee M J
Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, USA.
Clin Radiol. 1997 Jul;52(7):510-5. doi: 10.1016/s0009-9260(97)80327-3.
This study was undertaken to evaluate the potential efficacy of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) to detect renal tumours and to characterize indeterminate renal cysts.
Twenty-six PET scans were performed in 21 patients (14 PET scans in 10 patients with malignant renal tumours and 12 PET scans in 11 patients with Bosniak type 3 indeterminate renal cysts). Pathological proof was obtained in 18 of 21 patients (10 with solid neoplasms, eight with indeterminate cysts). Imaging was performed 1 h after injection of 5-10 mCi of FDG with IV administration of Lasix (10 mg) 20 mins after injection. Two consecutive 9.7-cm image segments were scanned to cover the entire renal areas.
PET accurately depicted solid neoplasms as areas of increased uptake in nine of 10 patients. Bilateral renal cell carcinomas were missed in one diabetic patient. All but one indeterminate renal cysts were correctly classified as benign (photopenic areas), but an indeterminate cyst with a 4-mm papillary neoplasm was wrongly classified as benign. There were no false positive PET interpretations. The mean tumour-to-kidney ratio was 3.0 for malignant lesions.
We conclude that FDG PET scanning shows promise in the evaluation of indeterminate renal cysts. A positive PET scan in the appropriate clinical setting obviates the need for cyst aspiration. A negative PET scan in conjunction with a negative cyst aspiration offers confirmatory evidence of benignity. Our preliminary results are encouraging and further work is ongoing.
本研究旨在评估氟-18 2-氟-2-脱氧-D-葡萄糖正电子发射断层扫描(FDG PET)检测肾肿瘤及对不确定肾囊肿进行特征性诊断的潜在效能。
对21例患者进行了26次PET扫描(10例恶性肾肿瘤患者进行了14次PET扫描,11例博斯尼亚克3型不确定肾囊肿患者进行了12次PET扫描)。21例患者中有18例获得了病理证实(10例为实性肿瘤,8例为不确定囊肿)。注射5 - 10 mCi FDG后1小时进行成像,注射后20分钟静脉注射速尿(10 mg)。扫描两个连续的9.7厘米图像段以覆盖整个肾脏区域。
PET准确地将10例患者中的9例实性肿瘤描绘为摄取增加区域。1例糖尿病患者双侧肾细胞癌未被检出。除1个不确定肾囊肿外,其余均被正确分类为良性(放射性缺损区),但1个伴有4毫米乳头状肿瘤的不确定囊肿被错误地分类为良性。PET检查无假阳性结果。恶性病变的平均肿瘤与肾脏摄取比值为3.0。
我们得出结论,FDG PET扫描在评估不确定肾囊肿方面显示出前景。在适当的临床情况下,PET扫描阳性可避免囊肿穿刺抽吸。PET扫描阴性结合囊肿穿刺抽吸阴性可提供囊肿为良性的确认证据。我们的初步结果令人鼓舞,进一步的工作正在进行中。